Silicone gel-filled breast implants were developed in 1962,
however, failed to obtain approval of the U.S. Food and Drug
Administration until 1976 and were not classified as class III
devices until 1988. In 1992, U.S. FDA declared a moratorium
on the sale of silicone breast implants. On November, 2006, the
U.S. FDA approved Allergan and Mentor’s application to market
its silicone-filled breast implants. On July, 2007, the Korea FDA
approved the application of both manufacturer’s. Cohesive silicone
gel implants are more soft and natural than saline
implants. Therefore, most patients for breast augmentation
nowadays tend to choose cohesive silicone gel implants. The
author think that cohesive silicone gel implants are more
suitable for thin Asian patients. Many patients who had saline
implants want to replace saline implants with cohesive silicone
gel. I strongly believe that many more patients would like to
make similar decisions in future.